Arrests made in 2010 $75M drug heist from Lilly warehouse
This article was originally published in Scrip
Two years ago thieves had pulled off a daring heist of more than $75 million worth of prescription drugs from a Lilly warehouse and storage facility in Enfield, Connecticut by scaling up the warehouse's outside walls and rappelling in and disabling parts of the security system. Now, through a series of indictments, federal authorities have arrested two brothers, both citizens of Cuba residing in Miami, Florida in connection with the heist and charged numerous others in what officials have pointed to as the break up of a cargo theft ring operating in several states.
You may also be interested in...
ChemoCentryx has successfully completed its initial public offering on Nasdaq, raising $45 million to help support its multiple R&D programmes. It sold 4.5 million shares at $10, a somewhat less ambitious debut than it had originally planned in January when it wanted to sell four million shares at $14-$16. The reduced offer is a sign of the challenging nature of the IPO market, but ChemoCentryx's assessment of its own worth was at least closer to the market’s assessment that Cempra which got its IPO away on 6 February at valuation that was less than two-thirds of that implied by its initial prospectus (scripintelligence.com, 7 February 2012).
Ampio Pharmaceuticals, a development-stage company, initially raised $15 million which was boosted to $16.9 million by the exercise of overallotments by brokers. The shares were offered at $3.25, an 8.5% discount to the closing price of $3.66 on 12 July. The market pushed them down slightly further to 3.21 on 13 July.
Verastem, a cancer stem cells startup, has moved quickly to build its pipeline just five months after an initial public offering. Management at the Cambridge, Massachusetts firm believes that recent moves have accelerated Verastem's clinical development plans by a year.